Amgen Inc
General ticker "AMGN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $147.7B
Amgen Inc follows the US Stock Market performance with the rate: 25.1%.
Estimated limits based on current volatility of 1.2%: low 259.24$, high 265.45$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-11-18, amount 2.25$ (Y3.40%)
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [224.16$, 324.80$]
- 2024-12-30 to 2025-12-30 estimated range: [229.31$, 337.01$]
Financial Metrics affecting the AMGN estimates:
- Positive: Operating profit margin, % of 28.01 > 19.51
- Positive: Non-GAAP EPS, $ of 18.65 > 2.29
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: 2.86 < Return on assets ratio (scaled to [-100,100]) of 6.47
- Negative: Operating cash flow per share per price, % of 5.79 <= 7.18
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term AMGN quotes
Long-term AMGN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $25,979.00MM | $26,323.00MM | $28,190.00MM |
| Operating Expenses | $18,340.00MM | $16,757.00MM | $20,293.00MM |
| Operating Income | $7,639.00MM | $9,566.00MM | $7,897.00MM |
| Non-Operating Income | $-938.00MM | $-2,220.00MM | $-42.00MM |
| Interest Expense | $1,197.00MM | $1,406.00MM | $2,875.00MM |
| R&D Expense | $4,819.00MM | $4,434.00MM | $4,784.00MM |
| Income(Loss) | $6,701.00MM | $7,346.00MM | $7,855.00MM |
| Taxes | $808.00MM | $794.00MM | $1,138.00MM |
| Profit(Loss) | $5,893.00MM | $6,552.00MM | $6,717.00MM |
| Stockholders Equity | $6,700.00MM | $3,661.00MM | $6,232.00MM |
| Inventory | $4,086.00MM | $4,930.00MM | $9,518.00MM |
| Assets | $61,165.00MM | $65,121.00MM | $97,154.00MM |
| Operating Cash Flow | $9,261.00MM | $9,721.00MM | $8,471.00MM |
| Capital expenditure | $880.00MM | $936.00MM | $1,112.00MM |
| Investing Cash Flow | $733.00MM | $-6,044.00MM | $-26,204.00MM |
| Financing Cash Flow | $-8,271.00MM | $-4,037.00MM | $21,048.00MM |
| Earnings Per Share* | $10.34 | $12.18 | $12.56 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.